ASTL Q1 2026 Earnings Narrowed Loss Beats Estimates Amid Operational Adjustments GFR Q1 2026 Earnings Negative EPS Disclosed Amid Limited Data Stock Rises 118 4D Molecular Therapeutics FDMT Q1 2026 Earnings NarrowerthanExpected Loss Lifts Shares CTAS Q1 2026 Earnings EPS Misses Estimates Stock Holds Steady GENB Q1 2026 Earnings WiderThanExpected Loss as PreRevenue Biotech Navigates Pipeline QH Q4 2021 Earnings Massive EPS Miss Amidst Operational Challenges ACRS Q1 2026 Earnings NarrowerThanExpected Loss Boosts Investor Sentiment Cullinan Therapeutics Inc CGEM Q1 2026 Earnings Beat on EPS with NarrowerThanExpected Loss CCC Q1 2026 Earnings EPS Surpasses Estimates by Nearly 15 BILL Q1 2026 Earnings EPS Beat Drives Modest Stock Decline Amid Revenue Data Gap WTW Q1 2026 Earnings EPS Slightly Beats Estimates as Stock Edges Lower CAPL Q1 2026 Earnings Strong EPS Surprise Despite Challenging Environment ARI Q1 2026 Earnings Earnings Miss by 20 as Credit Costs Weigh Stock Edges Higher